These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 2993397)

  • 1. Hemodynamic and clinical significance of the pulmonary vascular response to long-term captopril therapy in patients with severe chronic heart failure.
    Packer M; Lee WH; Medina N; Yushak M
    J Am Coll Cardiol; 1985 Sep; 6(3):635-45. PubMed ID: 2993397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative differences in the hemodynamic effects of captopril and nitroprusside in severe chronic heart failure.
    Packer M; Meller J; Medina N; Yushak M
    Am J Cardiol; 1983 Jan; 51(1):183-8. PubMed ID: 6336876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of captopril and isosorbide dinitrate on pulmonary arteriolar resistance and right ventricular function in patients with severe left ventricular failure: results of a randomized crossover study.
    Packer M; Medina N; Yushak M; Lee WH
    Am Heart J; 1985 Jun; 109(6):1293-9. PubMed ID: 3890506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative immediate hemodynamic and hormonal effects of amrinone and captopril in patients with severe chronic heart failure.
    Packer M; Medina N; Yushak M
    Am J Med Sci; 1986 Jan; 291(1):8-15. PubMed ID: 3510545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cooperative multicenter study of captopril in congestive heart failure: hemodynamic effects and long-term response.
    Chatterjee K; Parmley WW; Cohn JN; Levine TB; Awan NA; Mason DT; Faxon DP; Creager M; Gavras HP; Fouad FM
    Am Heart J; 1985 Aug; 110(2):439-47. PubMed ID: 3895877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure.
    Halperin JL; Faxon DP; Creager MA; Bass TA; Melidossian CD; Gavras H; Ryan TJ
    Am J Cardiol; 1982 Nov; 50(5):967-72. PubMed ID: 6182786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between serum sodium concentration and the hemodynamic and clinical responses to converting enzyme inhibition with captopril in severe heart failure.
    Packer M; Medina N; Yushak M
    J Am Coll Cardiol; 1984 Apr; 3(4):1035-43. PubMed ID: 6323565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of captopril in low-renin congestive heart failure: importance of sustained reactive hyperreninemia in distinguishing responders from nonresponders.
    Packer M; Medina N; Yushak M
    Am J Cardiol; 1984 Oct; 54(7):771-7. PubMed ID: 6091434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic and radionuclide effects of acute captopril therapy for heart failure: changes in left and right ventricular volumes and function at rest and during exercise.
    Massie B; Kramer BL; Topic N; Henderson SG
    Circulation; 1982 Jun; 65(7):1374-81. PubMed ID: 6280890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Converting-enzyme inhibitor therapy for chronic heart failure.
    Massie BM; Kramer BL; Topic N
    Herz; 1983 Apr; 8(2):71-80. PubMed ID: 6343210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy.
    Faxon DP; Halperin JL; Creager MA; Gavras H; Schick EC; Ryan TJ
    Am Heart J; 1981 May; 101(5):548-56. PubMed ID: 7013458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic and regional blood flow response to captopril in congestive heart failure.
    Levine TB; Olivari MT; Cohn JN
    Am J Med; 1984 May; 76(5B):38-42. PubMed ID: 6375361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.
    Ader R; Chatterjee K; Ports T; Brundage B; Hiramatsu B; Parmley W
    Circulation; 1980 May; 61(5):931-7. PubMed ID: 6244906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrasting hemodynamic responses in severe heart failure: comparison of captopril and other vasodilator drugs.
    Packer M; Medina N; Yushak M
    Am Heart J; 1982 Nov; 104(5 Pt 2):1215-23. PubMed ID: 6753552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effects of captopril on cardiopulmonary hemodynamics and renin-angiotensin-aldosterone and bradykinin profile in hypertension.
    Mookherjee S; Anderson GH; Eich R; Hill N; Smulyan H; Streeten DH; Vardan S; Warner R
    Am Heart J; 1983 Jan; 105(1):106-12. PubMed ID: 6336874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of diabetes mellitus on changes in left ventricular performance and renal function produced by converting enzyme inhibition in patients with severe chronic heart failure.
    Packer M; Lee WH; Medina N; Yushak M; Kessler PD; Gottlieb SS
    Am J Med; 1987 Jun; 82(6):1119-26. PubMed ID: 3037896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure.
    Packer M; Medina N; Yushak M; Meller J
    Circulation; 1983 Oct; 68(4):803-12. PubMed ID: 6352079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in pulmonary hemodynamics predict benefits in exercise capacity after ACE inhibition in patients with mild to moderate congestive heart failure.
    Pelliccia F; Borghi A; Ruggeri A; Cianfrocca C; Morgagni GL; Bugiardini R
    Clin Cardiol; 1993 Aug; 16(8):607-12. PubMed ID: 8370193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redistribution of regional blood flow following angiotensin-converting enzyme inhibition. Comparison of normal subjects and patients with heart failure.
    Faxon DP; Creager MA; Halperin JL; Bernard DB; Ryan TJ
    Am J Med; 1984 May; 76(5B):104-10. PubMed ID: 6203405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of oral angiotensin-converting enzyme inhibition with captopril therapy in severe chronic normotensive congestive heart failure.
    Awan NA; Evenson MK; Needham KE; Win A; Mason DT
    Am Heart J; 1981 Jan; 101(1):22-31. PubMed ID: 6257100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.